Regenerative Medical Technology (RMTG) Total Debt (2019 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Total Debt of $2.0 million for Q1 2026, little changed year-over-year from $2.0 million in Q1 2025, and little changed quarter-over-quarter from $2.0 million in Q4 2025.
Regenerative Medical Technology (RMTG) Total Debt (2019 - 2026) Analysis & Trends
Regenerative Medical Technology's Total Debt history runs 8 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Total Debt changed 0.0% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (changed 0.0% YoY), while the FY2025 annual figure was $2.0 million, changed 0.0% from the prior year.
- Total Debt for Q1 2026 stood at $2.0 million, roughly flat from $2.0 million in the prior quarter.
- The five-year high for Total Debt was $18.6 million in Q1 2024, with the low at $7800.0 in Q2 2022.
- The 5-year median for Total Debt is $2.8 million (2025), against an average of $7.8 million.
- The sharpest annual moves came in 2024 and 2025: Total Debt sank 99.96% in 2024, then surged 217128.6% in 2025.
- Regenerative Medical Technology's Total Debt stood at $15.1 million in 2022, then tumbled by 99.95% to $7800.0 in 2023, then surged by 25541.01% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025, then changed by 0.0% to $2.0 million in 2026.
- Business Quant data shows RMTG's Total Debt at $2.0 million in Q1 2026, $2.0 million in Q4 2025, and $16.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 9.34 Bn |
| 10 | Regenerative Medical Technology | 829,068.92 | -232,379.08 | 1.77 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 16.94 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 7,800.00 |
| Jun 30, 2024 | 39,981.00 |
| Mar 31, 2024 | 18.64 Mn |
| Dec 31, 2023 | 7,800.00 |
| Sep 30, 2023 | 17.36 Mn |
| Jun 30, 2023 | 16.60 Mn |
| Mar 31, 2023 | 8.76 Mn |
| Dec 31, 2022 | 15.07 Mn |
| Sep 30, 2022 | 14.64 Mn |
| Jun 30, 2022 | 7,800.00 |
| Mar 31, 2022 | 13.78 Mn |
| Dec 31, 2021 | 7,800.00 |
| Sep 30, 2021 | 7,800.00 |
| Jun 30, 2021 | 7,800.00 |